Response: Re: Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Torsten O. Nielsen(University of British Columbia), Matthew J. Ellis(University of California, Davis), Samuel Leung(BC Cancer Agency), Dongxia Gao(Baylor College of Medicine), Charles M. Perou(University of North Carolina at Chapel Hill), Stephen Chia(BC Cancer Agency), Maggie C.U. Cheang(Institute of Cancer Research), David Voduc(BC Cancer Agency), Philip S. Bernard(University of Utah)
Cited by 32
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k